Becton, Dickinson and Company
BDX
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $50.9B
$184.74
▼ -1.53%
P/E
55.64
Mkt Cap
$50.9B
52-Wk Range
$127.59–$193.07
52-Week Range
$127.59 - $193.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 22.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
No thesis available for this stock yet.
Smart-money signal
Who's buying BDX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $3.23 vs $3.14 consensus (+2.9% surprise). Revenue of $5.0B vs $4.9B expected (+2.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+2.9%
Revenue trend · last 8Q
—
+10%
+4%
+10%
+8%
+2%
-11%
-23%
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
Q2 26
Q3 26
$5.4B
$5.2B
$5.3B
$5.5B
$5.9B
$5.3B
$4.7B
$4.2B
Margins · last 8Q
Gross
—
Operating
12.7%
Profit
9.0%
Wall Street consensus
8 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 13, 2026
vs Industry
How BDX stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related